Bial Launches KYNMOBI® (Apomorphine Hydrochloride) in the United Kingdom January 7, 2026 The first sublingual therapy for the intermittent treatment of uncontrolled OFF episodes for adult people living with Parkinson’s Disease
CCC Digital Key™ Certifications Surged in 2025, Reinforcing the Global Standard for Secure Vehicle Access January 6, 2026 115 vehicle and module products achieved CCC Digital Key™ certification, including the first certified vehicles in China
Loomis Sayles Proudly Celebrates 100 Years of Client Commitment and Investment Excellence January 6, 2026 Loomis, Sayles & Company, the investment manager with $425 billion in assets under managementi, proudly marks its centennial year, celebrating a legacy of independent thinking and a relentless commitment to helping clients achieve their goals. Founded in January 1926, Loomis Sayles has grown to serving over 1,000 institutional clients in 28 countries offering differentiated investment [...]
Paris Saint-Germain Partners With Zing Coach Until 2027 to Encourage Fans to Get Active Through Interactive Fitness Experiences January 6, 2026 Paris Saint-Germain’s global fanbase will be offered the chance to engage in training routines modeled after their favorite Women and Men star players through Zing Coach’s AI-powered fitness platform, with top performers receiving exclusive experiences and prizes
Ikarovec to Advance Pipeline With Exclusive Worldwide Option to VectorBuilder’s Intravitreal Capsid Technology January 6, 2026 Novel capsid technology to enable convenient delivery in the doctor’s office of IKAR-003 for intermediate AMD, designed to prevent progression to sight-threatening disease
Iksuda to Present Preliminary Analysis of Oesophageal Cancer Data From Phase 1 study of IKS014 at ASCO Gastrointestinal Cancer Symposium January 6, 2026 Encouraging anti-tumour activity seen across all dose levels and in various tumour indications Clinical benefit rate of 80% for 10 patients with HER2+ oesophageal cancer who had received prior therapy that included a trastuzumab component in at least one prior treatment
Abu Dhabi’s TII Launches Falcon-H1 Arabic, Establishing the World’s Leading Arabic AI Model January 5, 2026 Based on new hybrid-architecture, models deliver higher accuracy while running on smaller parameter sizes Launch underscores UAE push to compete with global AI leaders in high-performance language models
TII Launches Falcon Reasoning: Best 7B AI Model Globally, Also Outperforms Larger Models January 5, 2026 Falcon H1R 7B Packs Advanced Reasoning into a Compact 7 Billion Parameter Model Optimized for Speed and Efficiency TII’s Latest AI Model Outperforms Larger Rivals from Microsoft, Alibaba, and NVIDIA on Key Benchmarks
Nex Playground Showcases Future of Active Play at CES and an Early “First Look” at its 2026 Product Roadmap January 5, 2026 Following a Blockbuster Holiday Season, the Company Shares International Growth Plan, New Sports Experiences, Expanded Content Lineup, and Connected Playdate Feature
Interactive Brokers’ Individual and Hedge Fund Clients Outperformed the S&P 500 on Average in 2025 January 2, 2026 Lower costs, global market access, and efficient execution contributed to stronger client outcomes.